4.5 Review

d-Serine, the Shape-Shifting NMDA Receptor Co-agonist

Journal

NEUROCHEMICAL RESEARCH
Volume 45, Issue 6, Pages 1344-1353

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11064-020-03014-1

Keywords

Astrocytes; d-Serine; Excitotoxicity; Glutamic acid; gamma-Amino-butyric acid (GABA); Serine racemase

Funding

  1. Whitehall Foundation [2018-05-107]
  2. BrightFocus Foundation [A2019034S]
  3. NIA [1R03AG063201-01]
  4. [R01MH05190]
  5. [P50MH0G0450]
  6. [R01NS098740-02]

Ask authors/readers for more resources

Shape-shifting, a phenomenon wide-spread in folklore, refers to the ability to physically change from one identity to another, typically from an innocuous entity to a destructive one. The amino acid d-serine over the last 25 years has shape-shifted into several identities: a purported glial transmitter activating N-methyl-d-aspartate receptors (NMDARs), a co-transmitter concentrated in excitatory glutamatergic neurons, an autocrine that is released at dendritic spines to prime their post-synaptic NMDARs for an instantaneous response to glutamate and an excitotoxic moiety released from inflammatory (A1) astrocytes. This article will review evidence in support of these scenarios and the artifacts that misled investigators of the true identity of d-serine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available